Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Original Article

    Pyrazole, Isoxazoline and Bypyrimidine Derivatives from Polygonum senegalense and Psiadia punctulata Flavonoids and their Anti-Microbial Activities

    wadmin2By wadmin2October 6, 2016Updated:August 12, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Evans Okemwa Kenandaa, Leonidah Kerubo Omosab
    aDepartment of Chemistry, School of Pure and Applied Sciences, Kisii University, P.O. Box 408-40200 Kisii, Kenya
    bDepartment of Chemistry, School of Physical Sciences, University of Nairobi, P.O. Box 30197-00100 Nairobi, Kenya

    Pharmacognosy Communications,2017,7,1,47-52.
    DOI:10.5530/pc.2017.1.7
    Published: October 2016
    Type: Original Article

    ABSTRACT

    Currently, researchers have given special attention to the synthesis of heterocyclic compounds with nitrogen and oxygen five in five- or six-membered ring systems. This is mainly due to their wide range of biological activities. Hence, in this study, isoxazoline, pyrazole and bypyrimidine derivatives were synthesized from flavonoids, previously isolated from Polygonum senegalense and Psiadia panctulata, and assessed for their anti-fungal activity. A flavone was reacted with hydrazine hydrate to afford a pyrazole analogue 5-methoxy-2-(5-(2,3,4,5-tetramethoxyphenyl)-1H-pyrazol-3-yl)benzene-1,3- diol (1) Two isoxazoline derivatives namely, 2-(4,5-dihydro-5-phenylisoxazol- 3-yl)-5-methoxybenzene-1,3-diol (2) and 2-(-4,5-dihydro-5-phenylisoxazol- 3-yl)-3,5-dimethoxyphenol (3) were successfully synthesized by the reaction of chalcones with hydroxylamine hydrochloride. An oxime derivative (4) was also generated from a similar procedure. A reaction between a chalcone and thiourea gave a bypyrimidine derivative, 4,5-dihydro-6-(2,4- dihydroxy-3,6-dimethoxyphenyl)-4-phenylpyrimidine-2-(1H)-thione (5). The products were then assessed for their anti-bacterial and anti-fungal activity. All compounds showed no significant activity except compound 2 that demonstrated activity against standard anti-bacterial agent, Streptococcus aureus with IC50 value of 7.56 and anti-fungal Candida neoformans, Candida krusei and Candida glabrata strains with IC50 values 8.01, 8.11 and 13.74 μg/mL respectively. We, therefore, recommend synthetic optimization of compound 2 as a potential anti-microbial agent.

    Key words: Bypyrimidine, Isoxazolines, Oxime, Pyrazole, Chalcones.

    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up